Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma
Authors:
- Vicky Ching-Har LaiVLVicky Ching-Har Lai
- Ching-Lung LaiCLChing-Lung Lai
Open Access
Abstract
BACKGROUND Increased expression of the proto‐oncogene c‐myc is a common phenomenon in hepatocellular carcinoma (HCC). The proto‐oncogenes c‐fos and c‐jun are involved in cell cycle progression and cellular proliferation. METHODS The objective of this study was to elucidate the mechanism of hepatocarcinogenesis with regard to the expressions of c‐myc, c‐fos, and c‐jun. One hundred fifty biopsied HCC specimens were stained immunohistochemically for the above phenotypic markers both in tumor tissue and in adjacent nontumor tissue. RESULTS Although the expression of c‐myc was high (74%) in tumor tissue, it was significantly less compared with the expression in nontumor tissue (100%; P = 0.0002). The expression of c‐myc was inversely proportional to the grade of differentiation in tumor tissue (P = 0.0108; correlation coefficient [r] = −0.244); that is, tissue with poorer histologic differentiation had a lower level of c‐myc expression. There were inverse associations between the expression of c‐myc and the expression of mutated p53 (P = 0.0017; r = −0.285) as well as the expression of Ki67 (P = 0.057; r = −0.147). There was significantly high expression of c‐fos in tumor tissue compared with the expression in nontumor tissue (91% vs. 0%; P < 0.0001). Both the tumor tissue and the nontumor tissue had high levels of expression of c‐jun (96.53% and 100%, respectively). There was a trend toward a positive association between the expression of c‐fos and the expression of c‐jun in tumor tissue (P = 0.07; r = 0.162). CONCLUSIONS Because c‐myc is a known inducer of wild type p53, decreased c‐myc expression may lead to uncontrolled cell growth because of the lack of p53 expression that normally induces apoptosis. The coordinated expression of c‐fos and c‐jun in HCC may reflect the coordinated tumor cell cycle of progression and proliferation; however, future studies are required to elucidate this possibility. Cancer 2001;91:106–12. © 2001 American Cancer Society.Keywords
This publication has 27 references indexed in Scilit:
- Transplant plenary sessions I & II, Sunday 8:00 a.m.Hepatology, 1995
- Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus‐associated hepatocellular carcinomaJournal of Medical Virology, 1994
- Histological Typing of Tumours of the Liver1994
- Activation of Protooncogene C-jun by the X Protein of Hepatitis B VirusVirology, 1993
- Cellular and Molecular Mechanisms of HepatocarcinogenesisSeminars in Liver Disease, 1992
- Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumourResearch in Virology, 1992
- Negative regulation of human c-fos expression by thes retinoblastoma gene productNature, 1990
- Hepatocellular CarcinomaAnnals of Internal Medicine, 1988
- Structural alterations in c-myc and c-Ha-ras proto-oncogenes in human hepatocellular carcinoma.The Kurume Medical Journal, 1988
- Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucksNature, 1986